TY  - JOUR
PY  - 2019//
TI  - Advice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 1. On medical care and treatment of injuries from blister and nerve agents
JO  - Toxicology
A1  - Timperley, Christopher M.
A1  - Forman, Jonathan E.
A1  - Abdollahi, Mohammad
A1  - Al-Amri, Abdullah Saeed
A1  - Baulig, Augustin
A1  - Benachour, Djafer
A1  - Borrett, Veronica
A1  - Cariño, Flerida A.
A1  - Geist, Michael
A1  - Gonzalez, David
A1  - Kane, William
A1  - Kovarik, Zrinka
A1  - Martínez-Álvarez, Roberto
A1  - Fusaro Mourão, Nicia Maria
A1  - Neffe, Slawomir
A1  - Raza, Syed K.
A1  - Rubaylo, Valentin
A1  - Suárez, Alejandra Graciela
A1  - Takeuchi, Koji
A1  - Tang, Cheng
A1  - Trifirò, Ferruccio
A1  - van Straten, Francois Mauritz
A1  - Vanninen, Paula S.
A1  - Vucinić, Slavica
A1  - Zaitsev, Volodymyr
A1  - Zafar-Uz-Zaman, Muhammad
A1  - Zina, Mongia Saïd
A1  - Holen, Stian
SP  - 56
EP  - 69
VL  - 415
IS  - 
N2  - The Scientific Advisory Board (SAB) of the Organisation for the Prohibition of Chemical Weapons (OPCW) has provided advice on assistance and protection in relation to the Chemical Weapons Convention. In this, the first of three sequential papers describing the SAB's work on this topic, we describe advice given in response to questions from the OPCW Director-General in 2013 and 2014 on the status of available medical countermeasures and treatments to blister and nerve agents. This paper provides the evidence base for this advice which recommended to the OPCW pretreatments, emergency care, and long-term treatments that were available at the time of the request for both classes of chemical warfare agent (CWA). It includes a bibliography of over 200 scientific references, which can be used as a platform for watching future medical countermeasure developments. The information provided in this paper should serve as a valuable reference for medical professionals and emergency responders who may have no knowledge of the symptoms and treatment options of exposure to CWAs.<br><br>Copyright © 2019. Published by Elsevier B.V.<p />  <p>Language: en</p>
LA  - en
SN  - 0300-483X
UR  - http://dx.doi.org/10.1016/j.tox.2019.01.004
ID  - ref1
ER  -